VEGF165, Bel-2,p53, COX-2 and HET-family expression in ptients with stage IB-IIIA completely resected Non-Small Cell Lung Cancer (NSCLC) and correlation with clinical outcome.

TIMOTHEADOU, E., S. MURRAY, H. LINARDOU, A. VRETTOU, Jana SKŘIČKOVÁ, P. KOSMIDIS, D. SKARLOS, D. PECTASIDES and G. FOUNTZILAS. VEGF165, Bel-2,p53, COX-2 and HET-family expression in ptients with stage IB-IIIA completely resected Non-Small Cell Lung Cancer (NSCLC) and correlation with clinical outcome. Journal of Clinical Oncology. 2005, vol. 23, No 1, p. 16. ISSN 0732-183X.

Basic information

Original name

VEGF165, Bel-2,p53, COX-2 and HET-family expression in ptients with stage IB-IIIA completely resected Non-Small Cell Lung Cancer (NSCLC) and correlation with clinical outcome.

Authors

TIMOTHEADOU, E., S. MURRAY, H. LINARDOU, A. VRETTOU, Jana SKŘIČKOVÁ, P. KOSMIDIS, D. SKARLOS, D. PECTASIDES and G. FOUNTZILAS

Edition

Journal of Clinical Oncology, 2005, 0732-183X

---

Other information

Type of outcome

Článek v odborném periodiku

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 11.810

Organization unit

Faculty of Medicine

UT WoS

000230326604361